Jiangbing Zhou, PhD

Dr. Jiangbing Zhou is the co-founder and Chief Technology Advisor of Couragene since its inception in 2022.

Dr. Zhou is a Professor of Neurosurgery and Biomedical Engineering at the Yale School of Medicine. He is a leading expert on the development of non-viral approaches for delivery of genetic medicines. He is an elected Fellow of the American Heart Association (AHA), the Royal Society of Chemistry (RSC), and the American Institute for Medical and Biological Engineering (AIMBE).

Dr. Zhou received a bachelor’s degree in chemical engineering from East China University of Science and Technology, a master’s degree in biochemistry and molecular biology from Tsinghua University, and a PhD degree in molecular microbiology and immunology from the Johns Hopkins University.